ASKA Pharmaceutical Holdings Co's quarterly market cap
increased
from Jun. 2023 (円40,756 Mil) to Sep. 2023 (円47,968 Mil) and
increased
from Sep. 2023 (円47,968 Mil) to Dec. 2023 (円50,457 Mil).
ASKA Pharmaceutical Holdings Co's annual market cap
declined
from Mar. 2022 (円35,596 Mil) to Mar. 2023 (円33,629 Mil) but then
increased
from Mar. 2023 (円33,629 Mil) to Mar. 2024 (円62,806 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ASKA Pharmaceutical Holdings Co's Enterprise Value for Today is 円57,263 Mil.
ASKA Pharmaceutical Holdings Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ASKA Pharmaceutical Holdings Co's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, ASKA Pharmaceutical Holdings Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASKA Pharmaceutical Holdings Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ASKA Pharmaceutical Holdings Co's Market Cap distribution charts can be found below:
* The bar in red indicates where ASKA Pharmaceutical Holdings Co's Market Cap falls into.
ASKA Pharmaceutical Holdings Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASKA Pharmaceutical Holdings Co (TSE:4886) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
ASKA Pharmaceutical Holdings Co Market Cap Related Terms
Thank you for viewing the detailed overview of ASKA Pharmaceutical Holdings Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.
ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4886 has been successfully added to your 